Cargando…

Building the Momentum for A Stronger Pharmaceutical System in Africa

Despite impressive progress, nearly two billion people worldwide have no access to essential medicines. The COVID-19 pandemic revealed Africa’s vulnerability due to its reliance on imports for most vaccines, medicines, and other health product needs. The vaccine manufacturing is complex and requires...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ussai, Silvia, Chillotti, Caterina, Stochino, Erminia, Deidda, Arianna, Ambu, Giovanni, Anania, Lorenzo, Boccalini, Alberto, Colombo, Flavia, Ferrari, Alessandra, Pala, Daniele, Puddu, Enrica, Rapallo, Giulia, Pistis, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956013/ https://www.ncbi.nlm.nih.gov/pubmed/35328999 http://dx.doi.org/10.3390/ijerph19063313

Ejemplares similares

Thyroid and renal tumors in patients treated with long-term lithium: case series from a lithium clinic, review of the literature and international pharmacovigilance reports
por: Ambrosiani, Luca, et al.
Publicado: (2018)

Clozapine toxicity due to a multiple drug interaction: a case report
por: Cadeddu, Giovanna, et al.
Publicado: (2015)

“Immuni” and the National Health System: Lessons Learnt from the COVID-19 Digital Contact Tracing in Italy
por: Ussai, Silvia, et al.
Publicado: (2022)

The smile is stronger than the handshake
por: Fine, Lauren, et al.
Publicado: (2020)

Does disease incite a stronger moral appeal than health?
por: Hofmann, Bjørn
Publicado: (2023)

Mood as Representation of Momentum
por: Eldar, Eran, et al.
Publicado: (2016)

Horsepox and the need for a new norm, more transparency, and stronger oversight for experiments that pose pandemic risks
por: Inglesby, Tom
Publicado: (2018)

Stronger tuberculosis laboratory networks and services in Africa essential to ending tuberculosis
por: Onyebujoh, Philip C., et al.
Publicado: (2017)

Squamous-cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept
por: Deidda, Arianna, et al.
Publicado: (2014)

Movement toward Environmentally Friendly Pharmaceuticals in Japan
por: Nagai, Kei
Publicado: (2023)

Recent Debate over How to Tackle Rapid Increases in Pharmaceutical Expenditure in Japan
por: Niki, Ryu
Publicado: (2020)

The “slower” the better
por: Pala, L., et al.
Publicado: (2014)

Efficacy of HPV Vaccination Regarding Vulvar and Vaginal Recurrences in Previously Treated Women: The Need for Further Evidence
por: Bechini, Angela, et al.
Publicado: (2023)

How to prevent the next Marathon Pharmaceuticals
por: David, Frank S., et al.
Publicado: (2018)

Older people: forgotten victims amid the Ukrainian humanitarian disaster
por: Armocida, Benedetta, et al.
Publicado: (2022)

The Paradox of Nuclear Lamins in Pathologies: Apparently Controversial Roles Explained by Tissue-Specific Mechanobiology
por: Urciuoli, Enrica, et al.
Publicado: (2022)

Activation of Investigator-Initiated Clinical Trials with a Pharmaceutical for Cancer Patients before and after Post-Millennial Changes of Regulations in Germany and Europe
por: Berdel, Wolfgang E.
Publicado: (2022)

Role of dopaminergic system in migraine
por: Cherchi, Alessandra, et al.
Publicado: (2001)

Acquiring Pharmaceutical Industry Assets in the UK: 1 + 1 = 1?
por: Kanavos, Panos, et al.
Publicado: (2014)

Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products
por: Frevert, Jürgen
Publicado: (2015)

Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology
por: Pala, Daniele, et al.
Publicado: (2021)

Development of Taiwan’s strategies for regulating nanotechnology-based pharmaceuticals harmonized with international considerations
por: Guo, Jiun-Wen, et al.
Publicado: (2014)

Public research funding and pharmaceutical prices: do Americans pay twice for drugs?
por: Conti, Rena M., et al.
Publicado: (2020)

Non-pharmaceutical strategies win coronavirus disease 2019 battle in New Zealand
por: Nhamo, Godwell, et al.
Publicado: (2020)

Advancing the Field of Pharmaceutical Risk Minimization Through Application of Implementation Science Best Practices
por: Smith, Meredith Y., et al.
Publicado: (2014)

Macrophage Activation in Follicular Conjunctivitis during the COVID-19 Pandemic
por: Gallenga, Carla Enrica, et al.
Publicado: (2023)

A surprising link with unexplained infertility: a possible Covid-19 paradox?
por: Pacchiarotti, Arianna, et al.
Publicado: (2020)

A(1) Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?
por: Vincenzi, Fabrizio, et al.
Publicado: (2020)

What Is Next for Public Health after COVID-19 in Italy? Adopting a Youth-Centred Care Approach in Mental Health Services
por: Ussai, Silvia, et al.
Publicado: (2022)

Pharma TARP: A Troubled Asset Relief Program for Novel, Abandoned Projects in the Pharmaceutical Industry
por: Bartfai, Tamas, et al.
Publicado: (2011)

Stronger synergies
por: Antonella Del Rosso
Publicado: (2012)

Hematopoietic Stem Cells Transplant (HSCT)-Related Chronic Pulmonary Diseases: An Overview
por: Traunero, Arianna, et al.
Publicado: (2023)

Together We are Stronger
por: Zimmerman, Karen G., et al.
Publicado: (2018)

Family meetings: how to build a stronger family and a stronger business
por: Aronoff, Craig E, et al.
Publicado: (2011)

Vaccination strategies for measles control and elimination: time to strengthen local initiatives
por: Cutts, F. T., et al.
Publicado: (2021)

Physical Activity Intensity Measurement and Health: State of the Art and Future Directions for Scientific Research
por: Rey-López, Juan Pablo, et al.
Publicado: (2023)

Evaluation of Concomitant Use of Anticancer Drugs and Herbal Products: From Interactions to Synergic Activity
por: Berretta, Massimiliano, et al.
Publicado: (2022)

Challenges in the Use of Artificial Intelligence for Prostate Cancer Diagnosis from Multiparametric Imaging Data
por: Corradini, Daniele, et al.
Publicado: (2021)

Safety of the feed additive consisting of vitamin B(2)/riboflavin (produced by Bacillus subtilis KCCM 10445) for all animal species (Hubei Guangji Pharmaceutical Co. Ltd.)
por: Bampidis, Vasileios, et al.
Publicado: (2022)

Safety and efficacy of the feed additive consisting of Vitamin B(2)/Riboflavin produced by Eremothecium ashbyi CCTCCM 2019833 for all animal species (Hubei Guangji Pharmaceutical Co., Ltd)
por: Bampidis, Vasileios, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bhudhpbt10fcrq43ju0lh68mq6